In the study, published in Gastroenterology, Duke researchers identified genomic subtypes that show marked differences in response.
Since the 1960s, gastroenterologists have noticed differences in responses to treatments in stomach cancer patients, suggesting the tumors were fundamentally different.
Read the Duke Health release on researchers identifying two different types of stomach cancer.
Related Articles on the Stomach:
Study: Women More Likely to Survive GI Surgery Than Men
Laparoscopic, Bariatric Breakthroughs on List of Upcoming Clinical Innovations
Study: Lap-Band Surgery Caused Complications in 40% of Patients After 12 Years
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
